INVESTMENT

Dallas-based Spectral MD-a predictive AI company focused on medical diagnostics and treatment guidance in wound care-was listed on Nasdaq earlier this month as Spectral AI. Now it’s making news again…

Plano-based global biotech company Reata Pharmaceuticals Inc. is being acquired by Biogen Inc. in a deal valued at roughly $7.3 billion. It’s an all-cash deal for $172.50 per share, the…

Parker Health, a health tech company headquartered in Dallas and Washington, DC, announced a milestone in its mission to “transform healthcare into the next century.” The startup secured $25 million…

Loopback Analytics, a Dallas-based provider of analytics and data-enabled services for health systems and life sciences organizations, announced a strategic growth investment by growth equity firm PSG. The amount of…

Austin-based Research Bridge Partners announced it will collaborate with Dallas’ Lyda Hill Philanthropies to support scientists at UT Southwestern Medical Center to turn their scientific discoveries into biotechnology companies—via initial…

Spectral MD Holdings, founded over a decade ago, is a predictive analytics company focused on wound care treatment. It plans to delist from the AIM market and list on Nasdaq…

MedArrive, an Irving-based mobile-integrated care management platform company, has received $8 million in new funding led by Cobalt Ventures, a wholly owned subsidiary of Blue Cross and Blue Shield of…

Coppell-based Recuro Health has closed a $47 million Series B investment round that includes both new and existing investors, including ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital,…

FYR Medical, a Forth Worth, TX-based medical device company, raised $2.6M in Series A funding. The round was led by NuVasive, which was joined by other firms and individual investors.…

CBRE Acquires Full Spectrum Group for $110M, Boosting Lab Solutions for Life Sciences Hubs > Dallas Innovates 11/10/2022 [Text, logo Description automatically generated]Nicole Ward Storyteller/Data Journalist Research & Innovation D:…